PatientMatch — Privacy-first clinical trial discovery

61 trials

Large B Cell LymphomaRecruiting now

Enrolling now24

Nationwide

A Phase II Trial of Loncastuximab Tesirine for Relapsed/Refractory Large B-cell Lymphoma After CAR T-cell Therapy

M.D. Anderson Cancer Center

Ph 2·~3yr·1 site in TX

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

CTX112 Trial

CRISPR Therapeutics AG

Ph 1/2·~7yr·4 sites in KS, MO, TX +1

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin Lymphoma

Janssen Research & Development, LLC

Ph 1/2·~6yr·14 sites in CA, CO, IA +8

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP

Danielle Wallace

Device·Ph 2·~5yr·1 site in NY

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

ACE1831 Trial

Acepodia Biotech, Inc.

Ph 1·~5yr·5 sites in FL, GA, IN +2

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

Autologous CD22 Chimeric Antigen Receptor (CAR) T Cells in w/Recurrent/Refractory B Cell Lymphomas

Stanford University

Ph 1·~7yr·1 site in CA

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

CAR-T Followed by Bispecific Antibodies

Abramson Cancer Center at Penn Medicine

Ph 2·~6yr·2 sites in NE, PA

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

DPX-Survivac and Pembrolizumab Trial

ImmunoVaccine Technologies, Inc. (IMV Inc.)

Ph 2·~4yr·17 sites in CA, FL, GA +8

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

Evaluation of Bridging Radiation Therapy Before CAR T-Cell Infusion for the Treatment of Relapsed or Refractory Large B-Cell Lymphoma

City of Hope Medical Center

Procedure·EARLY_Ph 1·~2yr·1 site in CA

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

Feasibility and Safety of Collecting Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy

Joshua Sasine, MD, PhD

Ph 1·~3yr·1 site in CA

Enrolling now

15q~4min

Check if I qualify View study

Nationwide

Fecal Microbiome Transplant Trial

City of Hope Medical Center

Procedure·Ph 2·~2yr·1 site in CA

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Bantam Pharmaceuticals

Ph 1·~3yr·1 site in TX

Enrolling now

10q~3min

Check if I qualify View study

Nationwide

Study of LYL314 in Aggressive Large B-Cell Lymphoma

Lyell Immunopharma, Inc.

Ph 1/2·~8yr·30 sites in CA, CO, GA +16

Enrolling now

8q~2min

Check if I qualify View study

Nationwide

Study of SGR-1505 in Mature B-Cell Neoplasms

Schrödinger, Inc.

Ph 1·~3yr·16 sites in AZ, DE, FL +10

Enrolling now

6q~2min

Check if I qualify View study

Nationwide

SynKIR-310 for Relapsed/Refractory B-NHL

Verismo Therapeutics

Ph 1·~4yr·5 sites in CO, GA, KS +2

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym

H. Lee Moffitt Cancer Center and Research Institute

Ph 2·~3yr·1 site in FL

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Phase 1/2 Study of STP938 for Adult Subjects With Relapsed/Refractory B-Cell and T-Cell Lymphomas

Step Pharma, SAS

Ph 1/2·~3yr·3 sites in CO, FL, NY

Enrolling now

16q~4min

Check if I qualify View study

Nationwide

A Study of AZD0486 for B-Cell Malignancies

AstraZeneca

Ph 1/2·~3yr·12 sites in MA, NC, NJ +6

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Nurix Therapeutics, Inc.

Ph 1·~6yr·18 sites in CA, CO, CT +11

Enrolling now

16q~4min

Check if I qualify View study

Nationwide

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

Jennifer Amengual

Device·Ph 2·~3yr·2 sites in CA, NY

Enrolling now

13q~3min

Check if I qualify View study

Nationwide

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Estrella Biopharma, Inc.

Ph 1/2·~4yr·2 sites in CA, TX

Enrolling now

12q~3min

Check if I qualify View study

Nationwide

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

SWOG Cancer Research Network

Procedure·Ph 2·~6yr·87 sites in AR, AZ, CA +24

Enrolling now

11q~3min

Check if I qualify View study

Nationwide

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

Vironexis Biotherapeutics Inc.

Ph 1/2·~6yr·9 sites in CA, CO, NC +5

Enrolling now

7q~2min

Check if I qualify View study

Nationwide

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

C. Babis Andreadis

Ph 1·~6yr·1 site in CA

Enrolling now

18q~5min

Check if I qualify View study